Terms: = Brain cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Prognosis
24 results:
1. Prognostic factors associated with the transition in treatment methods for brain metastases from colorectal cancer.
Imaizumi J; Shida D; Boku N; Igaki H; Itami J; Miyakita Y; Narita Y; Takashima A; Kanemitsu Y
Int J Clin Oncol; 2023 Aug; 28(8):1043-1053. PubMed ID: 37208499
[TBL] [Abstract] [Full Text] [Related]
2. Characterization of the Immune Cell Infiltration Landscape and a New Prognostic Score in Glioblastoma.
Wang J; Chi S
J Healthc Eng; 2022; 2022():4326728. PubMed ID: 35310188
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic significance of further genotyping H3G34 diffuse hemispheric gliomas.
Vuong HG; Le HT; Dunn IF
Cancer; 2022 May; 128(10):1907-1912. PubMed ID: 35195909
[TBL] [Abstract] [Full Text] [Related]
4. Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery.
Lin H; Wu Y; Liang G; Chen L
PLoS One; 2020; 15(11):e0242155. PubMed ID: 33170907
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic value of epidermal growth factor receptor gene mutation in resected lung adenocarcinoma.
Deng C; Zhang Y; Ma Z; Fu F; Deng L; Li Y; Chen H
J Thorac Cardiovasc Surg; 2021 Sep; 162(3):664-674.e7. PubMed ID: 32747123
[TBL] [Abstract] [Full Text] [Related]
6. Common genetic variations of deiodinase genes and prognosis of brain tumor patients.
Bunevicius A; Laws ER; Saudargiene A; Tamasauskas A; Iervasi G; Deltuva V; Smith TR; Bunevicius R
Endocrine; 2019 Dec; 66(3):563-572. PubMed ID: 31452060
[TBL] [Abstract] [Full Text] [Related]
7. Medulloblastoma and central nervous system germ cell tumors in adults: is pediatric experience applicable?
Mascarin M; Coassin E; Franceschi E; Gandola L; Carrabba G; Brandes AA; Massimino M
Childs Nerv Syst; 2019 Dec; 35(12):2279-2287. PubMed ID: 31414168
[TBL] [Abstract] [Full Text] [Related]
8. Identification of Potential Biomarkers with Diagnostic Value in Pituitary Adenomas Using Prediction Analysis for Microarrays Method.
Peng H; Deng Y; Wang L; Cheng Y; Xu Y; Liao J; Wu H
J Mol Neurosci; 2019 Nov; 69(3):399-410. PubMed ID: 31280474
[TBL] [Abstract] [Full Text] [Related]
9. Amide proton transfer imaging might predict survival and IDH mutation status in high-grade glioma.
Joo B; Han K; Ahn SS; Choi YS; Chang JH; Kang SG; Kim SH; Zhou J; Lee SK
Eur Radiol; 2019 Dec; 29(12):6643-6652. PubMed ID: 31175415
[TBL] [Abstract] [Full Text] [Related]
10. A Comparative Evaluation of the Cytotoxic and Antioxidant Activity of
Turkez H; Tozlu OO; Lima TC; de Brito AEM; de Sousa DP
Oxid Med Cell Longev; 2018; 2018():2083923. PubMed ID: 30057673
[TBL] [Abstract] [Full Text] [Related]
11. Blocking LINC00152 suppresses glioblastoma malignancy by impairing mesenchymal phenotype through the miR-612/akt2/NF-κB pathway.
Cai J; Zhang J; Wu P; Yang W; Ye Q; Chen Q; Jiang C
J Neurooncol; 2018 Nov; 140(2):225-236. PubMed ID: 30043319
[TBL] [Abstract] [Full Text] [Related]
12. Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
Ács B; Zámbó V; Vízkeleti L; Szász AM; Madaras L; Szentmártoni G; Tőkés T; Molnár BÁ; Molnár IA; Vári-Kakas S; Kulka J; Tőkés AM
Diagn Pathol; 2017 Feb; 12(1):20. PubMed ID: 28222768
[TBL] [Abstract] [Full Text] [Related]
13. Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis.
Téglási V; Reiniger L; Fábián K; Pipek O; Csala I; Bagó AG; Várallyai P; Vízkeleti L; Rojkó L; Tímár J; Döme B; Szállási Z; Swanton C; Moldvay J
Neuro Oncol; 2017 Aug; 19(8):1058-1067. PubMed ID: 28201746
[TBL] [Abstract] [Full Text] [Related]
14. IGFBP2 expression predicts IDH-mutant glioma patient survival.
Huang LE; Cohen AL; Colman H; Jensen RL; Fults DW; Couldwell WT
Oncotarget; 2017 Jan; 8(1):191-202. PubMed ID: 27852048
[TBL] [Abstract] [Full Text] [Related]
15. Distance to the neurooncological center: a negative prognostic factor in patients with glioblastoma multiforme. An epidemiological study.
Kerschbaumer J; Freyschlag CF; Bauer R; Obwegeser AA; Schubert GA; Thomé C; Seiz M
Anticancer Res; 2012 Dec; 32(12):5515-9. PubMed ID: 23225460
[TBL] [Abstract] [Full Text] [Related]
16. Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine.
Zhao Z; Liu Y; He H; Chen X; Chen J; Lu YC
Brain Res Bull; 2011 Oct; 86(3-4):189-94. PubMed ID: 21807073
[TBL] [Abstract] [Full Text] [Related]
17. Intracerebral and subarachnoid hemorrhage in patients with cancer.
Navi BB; Reichman JS; Berlin D; Reiner AS; Panageas KS; Segal AZ; DeAngelis LM
Neurology; 2010 Feb; 74(6):494-501. PubMed ID: 20142616
[TBL] [Abstract] [Full Text] [Related]
18. Gamma Knife surgery for the treatment of melanoma metastases: the effect of intratumoral hemorrhage on survival.
Redmond AJ; Diluna ML; Hebert R; Moliterno JA; Desai R; Knisely JP; Chiang VL
J Neurosurg; 2008 Dec; 109 Suppl():99-105. PubMed ID: 19123895
[TBL] [Abstract] [Full Text] [Related]
19. Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas.
Iwamoto FM; Nicolardi L; Demopoulos A; Barbashina V; Salazar P; Rosenblum M; Hormigo A
J Neurooncol; 2008 Jul; 88(3):293-8. PubMed ID: 18345516
[TBL] [Abstract] [Full Text] [Related]
20. Characterization of hemorrhagic complications after surgery for temporal lobe epilepsy.
Clusmann H; Kral T; Marin G; Van Roost D; Swamy K; Schramm J
Zentralbl Neurochir; 2004; 65(3):128-34. PubMed ID: 15306977
[TBL] [Abstract] [Full Text] [Related]
[Next]
